01
Confirm the legal structure
Current advice must address the actual intended parents, surrogate, donor, clinic, documents and relevant countries.
Pre-treatment legal checklist
Embryo transfer can make unresolved legal and documentary issues harder to correct. Use a formal pre-transfer gate that keeps clinical approval separate from legal readiness.
Concise summary
Before a proposed transfer, obtain current advice on the actual participant structure and countries involved; complete and reconcile agency, surrogate, donor, clinic, storage and payment documents; verify informed-consent and lawful record pathways; and map birth, travel and foreign-recognition evidence. Only qualified clinicians decide medical readiness. A legal checklist cannot confirm eligibility or guarantee pregnancy, parentage, registration, recognition or travel.
01
Current advice must address the actual intended parents, surrogate, donor, clinic, documents and relevant countries.
02
All material agreements, annexes, consents, instructions and payment schedules should be final, signed and internally consistent.
03
Know which records must exist during treatment, at birth and for later foreign authority use.
Provide Georgian counsel with the complete participant facts, including intended-parent status relevant to the proposed route, the surrogate and any donor structure, clinic and provider identity, proposed gametes or embryos, and timing. Georgia’s Health Care Law contains assisted-reproduction and written-consent provisions, but a general summary is not an individual eligibility opinion. Current Georgian text, implementing rules and evidence require review.
Coordinate destination-country advice before transfer. Ask whether the proposed arrangement, genetic facts, consent timing, records and Georgian birth documents support the expected parentage, nationality, passport, immigration and post-arrival route. If the foreign adviser identifies a required document or fact, ensure it can lawfully be created and preserved in Georgia before treatment proceeds.
Review the agency, surrogate, donor if relevant, clinic, storage and payment documents as one system. Confirm legal parties, responsibilities, governing terms, decision boundaries, compensation or expense pathways, confidentiality, records, changed circumstances, termination, birth cooperation and disputes. Ensure every incorporated schedule or policy has been supplied and that negotiated changes appear in the signed version.
Clinical consent must be managed by the treating provider for the relevant patient and procedure. Confirm the current consent version, identities, proposed embryo or gametes, recipient and permitted use. A private legal agreement should not be treated as a substitute for informed consent, and intended parents cannot assume authority to decide another patient’s care.
| Document group | Readiness test | Stop condition |
|---|---|---|
| Legal agreements | Final signed versions and annexes align | Material duty or participant remains undefined |
| Clinical consent | Current patient-specific consent recorded | Procedure, recipient or use is inconsistent |
| Storage and laboratory | Identifiers and release/use authority match | Material or instruction record is unclear |
| Foreign-law plan | Required evidence can be preserved | Recognition strategy depends on an unmet fact |
Create a version-controlled index of identity records, signed agreements, clinic consents, laboratory identifiers, screening completion confirmations, lawful information releases, payment milestones and current instructions. Limit access to health and genetic data to the lawful and necessary scope. Record who holds each original and how a later authority can obtain an accepted copy or explanation.
Confirm that payment obligations due before transfer are correctly triggered and documented, but do not let payment pressure replace legal or clinical readiness. Identify remaining reserves, contingent charges and consequences of cancellation or postponement. If a material discrepancy appears, obtain advice before withholding payment or directing a treatment change because those actions may have contractual effects.
Before transfer, establish who is responsible for pregnancy-stage legal updates, delivery preparation, medical birth evidence, Georgian registration, translations and certification, embassy or passport work and foreign recognition. The details will be refreshed later, but the strategy should not first be discovered near birth. Identify changes—such as destination, family status or participant facts—that require the plan to be reviewed again.
Ask destination-country counsel what contemporaneous evidence may be difficult to reconstruct after treatment: original consents, genetic or clinical records, authorised translations, professional statements or a particular sequence. Preserve it lawfully without over-collecting sensitive data. No agreement or checklist should promise an authority outcome or completion time.
Decision framework
Use a dated sign-off record. A legal green light is distinct from the clinic’s medical decision to proceed.
The following primary sources informed this guide. Official English translations and service pages are useful orientation, but current Georgian text, implementing rules, authority practice and the particular facts should be checked before individual advice is given.
Related legal support
Move from general information to a review of the actual documents, participants and countries involved.
Run a focused legal readiness gate before treatment advances.
Explore this serviceMaintain document and legal continuity across treatment and pregnancy.
Explore this serviceAssess participant, document, treatment and cross-border dependencies together.
Explore this serviceContinue reading
Legal guide
Apply patient-rights and record-access boundaries before transfer.
Read the guideLegal guide
Reconcile donor consent and permitted use where relevant.
Read the guideLegal guide
Continue the evidence plan from treatment into delivery preparation.
Read the guideResolve before transfer
Share the participant structure, countries, final agreements, consent and storage documents, payment status and proposed timing for a scoped review.